Dinakaran Balasubramanian Dinakaran Balasubramanian

Dinakaran is an accomplished commercial professional with rich experience of over 12 years in the pharmaceutical industry. He has an extensive understanding of the US commercial landscape and its key economic drivers, specifically in generic injectables and biosimilars.

Underlying Economics of Unbranded Biologics

FDA defines the term “unbranded biologic” or “unbranded biological product” as an approved brand ...

Dinakaran Balasubramanian
Dinakaran Balasubramanian
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call